THE co-existence of malignant lymphoma and chronic myeloid leukaemia has rarely been recorded. Because of the theoretical implications of such an association, the occurrence of lymphosarcoma in a woman with busulphantreated chronic myeloid leukaemia is here reported.
Case report
The patient, a 52-year-old housewife and shop assistant, presented in October 1964 with complaints of excessive tiredness recently, anorexia and weight loss. The latter may have occurred over a longer period of perhaps 9 months. The only abnormal clinical findings at that time were mild pyrexia (99°F), an appendicectomy scar and a palpable spleen tip, approximately 1 in. below the costal margin.
Investigations. Hb 12-9g/100ml, PCV 37%, WBC 49,400/mm3; 70% of the white cells were polymorphonuclear neutrophils, 10% metamyelocytes 6% myelocytes and 2% 'blast' cells. By the time she was admitted to hospital, 3 months later, the spleen was palable 4 in. below the costal margin, Hb had fallen to 1 1 g/ 100 ml and total WBC had risen to 186,900/mm3 (69 neutrophils 11 % metamyelocytes, 8% myelocytes and 3 % promyelocytes). Platelet count was then 793,000/mm3. Radiography revealed no evidence of hilar lymphadenopathy.
Busulphan therapy was commenced in January 1965. The courses and doses of this drug, and periodic white cell and platelet counts are shown in Fig.l Necropsy revealed haemorrhage into the right temporal lobe of the brain and bilateral basal bronchopneumonia. There was enlargement of cervical, axillary, inguinal, hilar and intraabdominal lymph nodes which had a fleshy appearance on section. The spleen weighed 1780g and was the site of numerous infarcts.
Discussion
There are numerous reports in the literature of leukaemia complicating various types of reticulosis, the association between chronic lymphatic leukaemia and lymphosarcoma being particularly well recognized. Acute leukaemia may be the terminal stage of reticulum cell sarcoma (Beutler, 1954; Zeffren & Ultmann, 1960) , lymphosarcoma (Sternberg, 1916; Flashman & Leopold, 1929) or Hodgkin's disease (Skworzoff, 1930; Skworzoff & Kazantzeva, 1930) . The association of chronic myeloid leukaemia with malignant lymphoma, however, remains rarely recorded; the complicating disease process has been reticulosarcoma (Hanns, Israel & Sacrez, 1934; Wilcken, 1957; Belotipetskaya & Gets, 1960 , lymphosarcoma (Yang, 1936 Forkner, 1938; Sardesai & Bhatia, 1959; Howell & Whitfield, 1963; Kurai & Papp, 1965; Wilson & van Slyck, 1966 ) and Hodgkin's disease (Samwick, Cohn & Swiller, 1955; Lacker & I group.bmj.com on November 6, 2017 -Published by http://pmj.bmj.com/ Downloaded from complicated by monocytic leukaemia (Craven, 1936) . Usually the diagnosis of chronic myeloid leukaemia has been established prior to recognition of the complicating disease, but in the case of Wilson & Van Slyck, a 54-year-old man, lymphosarcoma occurred 2 years before chronic myeloid leukaemia was detected (see Table 1 ).
Clinically the development of the second disease usually has been detected by lymphadenopathy-which occurred in the present casealthough soft tissue masses also occurred in some of the cases referred to. Lymphadenopathy, however, is a typical finding in the terminal illness of chronic myeloid leukaemia when it may be sudden and accompanied by fever and splenomegaly (Morrow et al., 1965) . The peripheral blood does not always show the characteristics of acute leukaemia at this time, although this is the usual finding. Lymphadenopathy in chronic myeloid leukaemia is said to be rare (Dameshek & Gunz, 1964) but that it may occur, and that it may indicate a different disease process, is noted by Hayhoe (1960) . When lymphadenopathy is found a rapidly progressive course of the leukaemic process has been anticipated (Emile-Weil & Isch-Wall, 1930; Scott, 1957) . Clearly it is impossible to differentiate clinically the onset of the terminal phase of chronic myeloid leukaemia from the development of a complicating malignant lymphoma and some form of microscopic examination of the enlarged nodes is indicated. In the present case, as in that of Konecni, Andrejevnic & Stosic (1957) , needle aspirates yielded cytologically diagnostic material, which was later confirmed by routine histological methods. At necropsy the findings were those of chronic myeloid leukaemia only-the cervical nodes having been shrunken by radiotherapy. The diagnosis of two disorders of this type presents some difficulties; lymph nodes showing apparently typical changes of reticulum cell sarcoma may yield Ph1 positive cells (Carbone, 1966) and extramedullary tumours which resemble reticulum cell sarcoma may occur in states of myeloid metaplasia (Lieberman, Rosvall & Ley, 1965) . In some cases the progression has shown cytological features of 'la remontee cellulaire evolutif' described by Bessis (e.g. Introzzi, 1955; Konecni et al., 1957) .
Both radiotherapy and alkylating agents are cytotoxic, mutagenic and carcinogenic, and it may be significant that all recorded cases had received one or other (sometimes mixed) forms of treatment. It has been postulated that myeloid proliferation might be partially controlled in these cases and any stimulus to abnormal proliferation therefore allowed to act more effectively on lymphoid tissues (Howell & Whitfield, 1963) . Such a sequence of events could be interpreted as support for the lymphoid origin of myeloid cells suggested by Maximow & Bloom (1948) ; this view also has the support of Yoffey et al. (1961) although disputed by Ham (1961) . The coexistence of lymphosarcoma, myeloid leukaemia and myeloma in a 70-year-old man might be regarded similarly (Hollard et al. 1965) . That two previous cases were reported from this centre suggests that this event may not be very rare, and indicates the need for critical assessment of lymphadenopathy arising in the course of chronic myeloid leukaemia.
When 'lymphoma' complicates chronic myeloid leukaemia the leukaemia usually has been of the Philadelphia-negative type (Wilson & Van Slyck, 1966) . Repeated attempts in the present case failed to produce satisfactory metaphase plates and we therefore cannot comment on this particular aspect of the problem from personal experience.
In some cases of chronic myeloid leukaemia it has not been possible to demonstrate the Philadelphia abnormality (Tjio et al., 1966) and such patients appear to have a relatively poor prognosis; there has also been a high incidence of prior radiotherapy in such cases (Tough et al., 1962 . It would seem useful to report the findings in all cases where lymphoma develops as the numbers are presently too small to allow any conclusions to be drawn concerning the role of the Philadelphia chromosome in this situation.
The interesting findings of Josephs, Zarafonetis & Durant (1966) The final consideration is whether such cases are to be regarded in any other way than examples of coincidence. The increasing numbers of observations suggest that this may not be the correct view but until much larger numbers are available for analysis it is not possible to arrive at any firm conclusion.
